IN8bio to Present at Cantor Oncology & HemOnc Conference

September 27, 2022

https://www.globenewswire.com/news-release/2022/09/27/2523208/0/en/IN8bio-to-Present-at-Cantor-Oncology-HemOnc-Conference.html

NEW YORK, Sept. 27, 2022 (GLOBE NEWSWIRE) — IN8bio, Inc. (Nasdaq:INAB), a clinical-stage biopharmaceutical company discovering and developing innovative gamma-delta T cell therapies that utilize its DeltEx platform, today announced that William Ho, IN8bio’s Chief Executive Officer, will be a speaker on the “Cell Therapy in Solid Tumors” panel at the Cantor Oncology & HemOnc Conference. The panel will take place at 1:45 p.m. ET on September 28, 2022.

Read more at globenewswire.com

Related news for (INAB)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.